Diabetes Market Players Increase Interest in Molecules, Claims Kuick Research in Its New Study Available at MarketPublishers.com
London, UK (PRWEB) April 10, 2015 -- The diabetes drug market is witnessing rapid growth. Its growth is encouraged by rising demand and also by escalating disease incidences from pole to pole. Other factors spurring the market growth include a large patient base and ongoing technological developments. Huge investments in various research and development activities also support the market growth. At present, the clinical pipeline encompasses approximately 820 drugs for treatment of multiply diabetes conditions; more than 50 percent of these drugs are in a preclinical phase. Furthermore, 99 drugs are commercially available in the market.
Some molecules which belong to different classes (e.g. insulin sensitizers) are currently screened for effects they have on diabetes. They are expected to provide better safety as well as efficacy profiles if compared to existing diabetes drugs. Such molecules are easy to produce. Besides, they offer higher cost effectiveness. Consequently, pharma players are expected to become increasingly interested in this market segment in the upcoming years.
Some of key companies in the diabetes marketplace comprise: AstraZeneca, Eli Lily, Sanofi, to name a few.
New market research report “Global Diabetes Drug Market & Pipeline Insight 2015” drawn up by Kuick Research is now available at MarketPublishers.com.
Report Details:
Title: Global Diabetes Drug Market & Pipeline Insight 2015
Published: April, 2015
Pages: 1100
Price: US$ 2,400.00
https://marketpublishers.com/report/pharmaceuticals/drugs/global-diabetes-drug-market-pipeline-insight-2015.html
The study offers a comprehensive guide to the global market for diabetes drugs. It casts light on the current market scenario and provides a thorough overview of the global diabetes drug pipeline. The report investigates market dynamics and investigates future market opportunities. It canvasses the drug pipeline and explores the competitive landscape. The research study also profiles market players.
Report Scope:
• a bird’s eye view of the marketplace;
• a comprehensive overview of the diabetes drug pipeline;
• an analysis of the diabetic drug clinical pipeline on the basis of company and phase;
• examination of the competitive landscape;
• company profiles;
• investigation of market prospects;
• and more.
More in-demand research reports by the publisher can be found at Kuick Research page.
Natalie Aster, TD The Market Publishers, Ltd, https://marketpublishers.com/, +44 2081446009, [email protected]
Share this article